Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy

OBJECTIVE: The aim of this study was to calculate the range of absorbed doses that could potentially be delivered by a variety of radiopharmaceuticals and typical fixed administered activities used for bone pain palliation in a cohort of patients with metastatic castration-resistant prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis-Bacelar, Ana M, Chittenden, Sarah J, McCready, V Ralph, Divoli, Antigoni, Dearnaley, David P, O’Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2018
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966004/
https://www.ncbi.nlm.nih.gov/pubmed/29293372
http://dx.doi.org/10.1259/bjr.20170795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966004/
https://www.ncbi.nlm.nih.gov/pubmed/29293372
http://dx.doi.org/10.1259/bjr.20170795

Ejemplares similares